Not a member? Sign up for free!

Hospital Utilization Following Antipsychotic Medication Dose Reduction: Balancing Side Effect Management With Risk Of Relapse

Research Summary | January 10, 2019

Not a member? Sign up for free!

Join us as we continue our efforts towards improving the future of mental health care through information, discussion, and collaboration.
Sign up today for instant access to all PsychU offerings. Membership is free!

Join PsychU

Background & Purpose Direct health care costs for schizophrenia were estimated to be approximately $38 billion in 2013, with inpatient admissions accounting for 60-70% of that expense. The cost of care for patients who relapse has been estimated to be up to five times higher than costs for non- relapsed patients. As schizophrenia has a…

You must be logged in to read the full article: Join PsychU or Log In